Skip to main content
SpringerLink
Log in
Book cover

Clinical Ophthalmic Oncology pp 159–184Cite as

Conjunctival and Corneal Tumors: Ocular Surface Squamous Neoplasia

  • Chapter
  • First Online:

  • 491 Accesses

Abstract

Ocular surface squamous neoplasia (OSSN) is a term used for precancerous and cancerous epithelial lesions of the conjunctiva and cornea. It is more common in countries with high exposure to solar ultraviolet radiation. The two other major etiological factors in the development of OSSN are human papillomavirus and AIDS. The OSSN lesions arise commonly within the interpalpebral fissure, mostly at the limbus. It may be difficult to differentiate clinically between conjunctival intraepithelial neoplasia (CIN) and invasive squamous cell carcinoma. Despite modern imaging techniques, the definite diagnosis is made by incisional or excisional biopsy. Surgical excision of OSSN is the traditional method of treatment. Adjuvant cryotherapy and brachytherapy have been used to reduce the recurrence rate. Since the 1990s, topical medical therapy has been used extensively as the sole treatment or as an adjuvant to surgical excision. Topical drops of mitomycin C, 5-fluorouracil, and interferon-α2b, have shown promising results, lowering the recurrence rate significantly. Intraocular invasion and metastasis of conjunctival squamous cell carcinoma are extremely rare.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39(6):429–50.

    CAS  PubMed  Google Scholar 

  2. Pe’er J. Ocular surface squamous neoplasia. Ophthalmol Clin N Am. 2005;18(1):1–13.

    Google Scholar 

  3. Pizzarello LD, Jakobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Jakobiec FA, editor. Ocular and adnexal tumors. Birmingham: Aesculapius; 1978. p. 553–71.

    Google Scholar 

  4. Margo CE, White AA. Ocular surface squamous neoplasia: terminology that is conceptually friendly but clinically perilous. Eye. 2014;28:507–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Sun EC, Fears TR, Goedert JJ. Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomark Prev. 1997;6(2):73–7.

    CAS  Google Scholar 

  6. Gupta N, Sachdev R, Tandon R. Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome. Graefes Arch Clin Exp Ophthalmol. 2011;249(8):1217–21.

    PubMed  Google Scholar 

  7. Kao AA, Galor A, Karp CL, et al. Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Balmer Eye Institute: 2001 to 2010. Ophthalmology. 2012;119:1773–6.

    PubMed  Google Scholar 

  8. Erie JC, Campbell RJ, Liesegang J. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93(2):176–83.

    CAS  PubMed  Google Scholar 

  9. Newton R, Ferlay J, Reeves G, et al. Effect of ambient solar ultraviolet radiation on incidence of squamous cell carcinoma of the eye. Lancet. 1996;347(9013):1450–1.

    CAS  PubMed  Google Scholar 

  10. Gichuhi S, Ohnuma S, Sagoo MS, et al. Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res. 2014;129:172–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Scholz SL, Thomasen H, Reis H, et al. Frequent TERT promoter mutations in ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci. 2015;56:5854–61.

    CAS  PubMed  Google Scholar 

  12. Lin SY, Liao SL, Hong JB, et al. TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis. Br J Ophthalmol. 2016;100:274–7.

    PubMed  Google Scholar 

  13. McDonnell JM, Mayr AJ, Martin WJ. DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med. 1989;320(22):1442–6.

    CAS  PubMed  Google Scholar 

  14. Guthoff R, Marx A, Stroebel P. No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany. Curr Eye Res. 2009;34(8):666–71.

    PubMed  Google Scholar 

  15. Waddell K, Magyezr J, Boursaghin L, et al. Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda. Br J Cancer. 2003;88(12):2002–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hanbazazh M, Gyure KA. Ocular human papillomavirus infections. Arch Pathol Lab Med. 2018;142:706–10.

    PubMed  Google Scholar 

  17. Chauhan S, Sen S, Sharma A, et al. Human papillomavirus: a predictor of better survival in ocular surface squamous neoplasia patients. Br J Ophthalmol. 2012;96(12):1517–21.

    PubMed  Google Scholar 

  18. Goedert JJ, Cote TR. Conjunctival malignant disease with AIDS in USA. Lancet. 1995;346(8969):257–8.

    CAS  PubMed  Google Scholar 

  19. Gichuhi S, Macharia E, Kabiru J, et al. Clinical presentation of ocular surface squamous neoplasia in Kenya. JAMA Ophthalmol. 2015;133:1305–13.

    PubMed  PubMed Central  Google Scholar 

  20. Perry JD, Polito SC, Chundury RV, et al. Periocular skin cancer in solid organ transplant recipients. Ophthalmology. 2016;123(1):203–8.

    PubMed  Google Scholar 

  21. Dahlke E, Murray CA, Kitchen J, et al. Systematic review of melanoma incidence and prognosis in solid organ transplant recipients. Transplant Res. 2014;6(3):10.

    Google Scholar 

  22. Clarke CA, Morton LM, Lynch C, et al. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013;9:109.

    Google Scholar 

  23. Kim C, Cheng J, Colegio OR. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment. Semin Oncol. 2016;43:390–4.

    CAS  PubMed  Google Scholar 

  24. Shields CL, Ramasubramanian A, Mellen PL, et al. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection). Ophthalmology. 2011;118:2133–7.

    PubMed  Google Scholar 

  25. Ashkenazy N, Karp CL, Wang G, et al. Immunosuppression as a possible risk factor for interferon nonresponse in ocular surface squamous neoplasia. Cornea. 2017;36:506–10.

    PubMed  PubMed Central  Google Scholar 

  26. Lehmann J, Seebode C, Martens MC, et al. Xeroderma Pigmentosum – facts and perspectives. Anticancer Res. 2018;38:1159–64.

    CAS  PubMed  Google Scholar 

  27. Lim R, Sethi M, Morley AMS. Ophthalmic manifestations of Xeroderma Pigmentosum: a perspective from the United Kingdom. Ophthalmology. 2017;124:1652–61.

    PubMed  Google Scholar 

  28. Chaurasia S, Mulay K, Ramappa M, et al. Corneal changes in xeroderma pigmentosum: a clinicopathologic report. Am J Ophthalmol. 2014;157:495–500.

    PubMed  Google Scholar 

  29. Brooks BP, Thompson AH, Bishop RJ, et al. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. Ophthalmology. 2013;120:1324–36.

    PubMed  PubMed Central  Google Scholar 

  30. Suarez MJ, Rivera-Michlig R, Dubovy S, et al. Clinicopathological features of ophthalmic neoplasms arising in the setting of Xeroderma Pigmentosum. Ocul Oncol Pathol. 2015;2:112–21.

    PubMed  PubMed Central  Google Scholar 

  31. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164–8.

    CAS  PubMed  Google Scholar 

  32. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997;104(12):2085–93.

    CAS  PubMed  Google Scholar 

  33. Wilson FM 2nd. Rose bengal staining of epibulbar squamous neoplasms. Ophthalmic Surg. 1976;7(2):21–3.

    PubMed  Google Scholar 

  34. Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea. 2009;28:732–4.

    PubMed  Google Scholar 

  35. Romero IL, Barros JD, Martins MC, et al. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia. Cornea. 2012;32(1):36–9.

    Google Scholar 

  36. Finger PT, Tran HV, Turbin RE, et al. High-frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma. Arch Ophthalmol. 2003;121(2):168–72.

    PubMed  Google Scholar 

  37. Xu Y, Zhou Z, Xu Y, et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye (Lond). 2012;26(6):781–7.

    CAS  Google Scholar 

  38. Kieval JZ, Carp CL, Abou Shousha M, et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology. 2012;119(3):481–6.

    PubMed  Google Scholar 

  39. Atallah M, Joag M, Galor A, et al. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases. Ocul Surf. 2017;15:688–95.

    PubMed  PubMed Central  Google Scholar 

  40. Spinak M, Friedman AH. Squamous cell carcinoma of the conjunctiva. Value of exfoliative cytology in diagnosis. Surv Ophthalmol. 1977;21(4):351–5.

    CAS  PubMed  Google Scholar 

  41. Semenova EA, Milman T, Finger PT, et al. The diagnostic value of exfoliative cytology vs. histopathology for ocular surface squamous neoplasia. Am J Ophthalmol. 2009;148(5):772–8.

    PubMed  Google Scholar 

  42. Nolan GR, Hirst LW, Bancroft BJ. The cytomorphology of ocular surface squamous neoplasia by using impression cytology. Cancer. 2001;93(1):60–7.

    CAS  PubMed  Google Scholar 

  43. Asnaghi L, Alkatan H, Mahale A, et al. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci. 2014;9(55):8604–13.

    Google Scholar 

  44. Mishra DK, Veena U, Kaliki S, et al. Differential expression of stem cell markers in ocular surface squamous neoplasia. PLoS One. 2016;11:e0161800.

    PubMed  PubMed Central  Google Scholar 

  45. AJCC Opthalmolic Oncology Task Force. Carcinoma of the conjunctiva. In: American Joint Committee on Cancer (AJCC) Cancer staging manual. 7th ed. New York: Springer; 2010.. Chapter 49, p. 531–7.

    Google Scholar 

  46. Conway RM, Graue GF, Pelaye DE, et al. Conjunctiva carcinoma. In: American Joint Committee on Cancer (AJCC) Cancer staging manual. 8th ed. New York: Springer; 2017., Chapter 65. p. 787–93.

    Google Scholar 

  47. Bellerive C, Berry JL, Polski A, et al. Conjunctival squamous neoplasia: staging and initial treatment. Cornea. 2018;37(10):1287–91.

    PubMed  Google Scholar 

  48. Chauhan S, Sen S, Sharma A, et al. American Joint Committee on cancer staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India. Arch Pathol Lab Med. 2014;138:1488–94.

    PubMed  Google Scholar 

  49. Waring GO III, Roth AM, Ekins MB. Clinical and pathologic description of 17 cases of corneal intraepithelial neoplasia. Am J Ophthalmol. 1984;97(5):547–59.

    PubMed  Google Scholar 

  50. Espana EM, Levine M, Schoenfield L, et al. Ocular surface squamous neoplasia in an anophthalmic socket 60 years after enucleation. Surv Ophthalmol. 2011;56(6):539–43.

    PubMed  Google Scholar 

  51. Iliff WJ, Marback R, Green WR. Invasive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol. 1975;93(2):119–22.

    CAS  PubMed  Google Scholar 

  52. Char DH, Crawford JB, Howers EL, et al. Resection of intraocular squamous cell carcinoma. Br J Ophthalmol. 1992;76(2):123–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Buus DR, Tse DT, Folberg R. Microscopically controlled excision of conjunctival squamous cell carcinoma. Am J Ophthalmol. 1994;117(1):97–102.

    CAS  PubMed  Google Scholar 

  54. Shields JA, Shields CL, Gunduz K, et al. The 1998 Pan American Lecture. Intraocular invasion of conjunctival squamous cell carcinoma in five patients. Ophthal Plast Reconstr Surg. 1999;15(3):153–60.

    CAS  PubMed  Google Scholar 

  55. Fraunfelder FT, Wallace TR, Farris HE, et al. The role of cryosurgery in external ocular and periocular disease. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(4 Pt. 1):713–24.

    CAS  PubMed  Google Scholar 

  56. Lommatzsch P. Beta-ray treatment of malignant epithelial tumors of the conjunctiva. Am J Ophthalmol. 1976;81(2):198–206.

    CAS  PubMed  Google Scholar 

  57. Zehetmayer M, Menapace R, Kulnig W. Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. Ophthalmologica. 1993;207(3):133–9.

    CAS  PubMed  Google Scholar 

  58. Marr BP, Abramson DH, Cohen GN, et al. Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity. JAMA Ophthalmol. 2015;133:283–9.

    PubMed  PubMed Central  Google Scholar 

  59. Arepalli S, Kaliki S, Shields CL, et al. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes. JAMA Ophthalmol. 2014;132:691–6.

    PubMed  Google Scholar 

  60. El-Assal KS, Salvi SM, Rundle PA, et al. Treatment of invasive ocular surface squamous neoplasia with proton beam therapy. Eye (Lond). 2013;27:1223–4.

    CAS  Google Scholar 

  61. Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol. 2006;90(7):819–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Hirst LW. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Ophthalmology. 2007;114(5):976–82.

    PubMed  Google Scholar 

  63. Russell HC, Chadha V, Lockington D, et al. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol. 2012;94(10):1316–21.

    Google Scholar 

  64. Prabhasawat P, Tarinvorakup P, Tesavibul N, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24:443–8.

    PubMed  Google Scholar 

  65. Lichtinger A, Pe’er J, Frucht-Pery J, et al. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. Ophthalmology. 2010;117:431–7.

    PubMed  Google Scholar 

  66. Frucht-Pery J, Rozenman Y, Pe’er J. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002;109(3):548–52.

    PubMed  Google Scholar 

  67. Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea. 2002;21:12–6.

    PubMed  Google Scholar 

  68. Sarici AM, Arvas S, Pazarli H. Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 2013;251:2201–4.

    CAS  PubMed  Google Scholar 

  69. Joag MG, Sise A, Murillo JC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123:1442–8.

    PubMed  PubMed Central  Google Scholar 

  70. Parrozzani R, Frizziero L, Trainiti S, et al. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101:1094–9.

    PubMed  Google Scholar 

  71. Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108(6):1093–8.

    CAS  PubMed  Google Scholar 

  72. Galor A, Karp CL, Chhabra S, et al. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia; a dose comparison study. Br J Ophthalmol. 2010;94(5):551–4.

    CAS  PubMed  Google Scholar 

  73. Shields CL, Kaliki S, Kim HJ, et al. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on cancer classification. Cornea. 2013;32(3):248–56.

    PubMed  Google Scholar 

  74. Krilis M, Tsang H, Coroneo M. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Ophthalmology. 2012;119:1969–73.

    PubMed  Google Scholar 

  75. Karp CL, Galor A, Chhabra S, et al. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117:2241–6.

    PubMed  Google Scholar 

  76. Nanji AA, Moon CS, Galor A, et al. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmology. 2014;121:994–1000.

    PubMed  PubMed Central  Google Scholar 

  77. Espana EM, Prabhasawat P, Grueterich M, et al. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol. 2002;86(6):640–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Palamar M, Kaya E, Egrilmez S, et al. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye. 2014;28:1131–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Galor A, Karp CL, Oellers P, et al. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology. 2012;119(10):1974–81.

    PubMed  PubMed Central  Google Scholar 

  80. Murillo JC, Galor A, Wu MC, et al. Intracorneal and intraocular invasion of ocular surface squamous neoplasia after intraocular surgery: report of two cases and review of the literature. Ocul Oncol Pathol. 2017;3:66–72.

    PubMed  Google Scholar 

  81. Holkar S, Mudhar HS, Jain A, et al. Regression of invasive conjunctival squamous carcinoma in an HIV-positive patient on antiretroviral therapy. Int J STD AIDS. 2005;16(12):782–3.

    CAS  PubMed  Google Scholar 

  82. Ganapathy PS, Plesec T, Singh AD. Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus). Am J Ophthalmol Case Rep. 2017;6:1–3.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Oncology Service and Ophthalmic Pathology Laboratory, Department of Ophthalmology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel

    Jacob Pe’er & Shahar Frenkel

  2. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

Authors
  1. Jacob Pe’er
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahar Frenkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arun D. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob Pe’er .

Editor information

Editors and Affiliations

  1. Ocular Onocology Service and Ophthalmic Pathology Laboratory, Department of Ophthalmology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel

    Jacob Pe'er

  2. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

  3. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK

    Bertil E. Damato

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pe’er, J., Frenkel, S., Singh, A.D. (2019). Conjunctival and Corneal Tumors: Ocular Surface Squamous Neoplasia. In: Pe'er, J., Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-06046-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-06046-6_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-06045-9

  • Online ISBN: 978-3-030-06046-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation